Zdrowie i gospodarka · 26/07/2011
FDA Classifies Repetitive Transcranial Magnetic Stimulation System as Class II Device
The US Food and Drug Administration has classified the repetitive transcranial magnetic stimulation (rTMS) system as a Class II device, requiring special controls to ensure the device's safety and effectiveness.